Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985412 · ClinicalTrials.gov registry record
Genome Transplant Dynamics: Non-invasive Sequencing-based Diagnosis of Rejection
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 65
- Enrollment target
NCT01985412: Completed study, sponsored by Stanford University.
NCT01985412 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01985412 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether shotgun sequencing technology, which can be used to detect donor DNA in recipient plasma, can be used as a rapid, accurate, non-invasive method to detect Acute Cellular Rejection (ACR) after heart transplantation. Currently, all heart transplant recipients undergo invasive heart biopsies to diagnose ACR. Thus, there is an ongoing need to monitor patients for the development of acute and chronic rejection, with the primary goal of non-invasive early detection and treatment to prevent organ damage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01985412
The ClinicalTrials.gov registry entry for NCT01985412 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01985412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01985412 about?
NCT01985412 is a clinical study titled "Genome Transplant Dynamics: Non-invasive Sequencing-based Diagnosis of Rejection". The purpose of this study is to determine whether shotgun sequencing technology, which can be used to detect donor DNA in recipient plasma, can be used as a rapid, accurate, non-invasive method to detect Acute Cellular Rejection (ACR) after heart transplantation. Currently, all heart transplant reci...
What is the current status of trial NCT01985412?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2010-03. Estimated completion is 2013-09-29.
Who is sponsoring clinical trial NCT01985412?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.